ABCB1 and leukemia: For these reasons, several therapies have been focused on the inhibition of ABCB1. To date, three generations of MDR1 inhibitors have been developed since 1981, when Tsuruo et al. found that the MDR of vincristine‐resistant P388/VCR leukaemia cells could be reversed by verapamil 5.